Corcept Therapeutics (NASDAQ:CORT) reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Corcept Therapeutics missed estimated earnings by 26.32%, reporting an EPS of $0.14 versus an estimate of $0.19.
Revenue was up $11.95 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.08 which was followed by a 4.66% drop in the share price the next day.
Here’s a look at Corcept Therapeutics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.22 | 0.22 | 0.21 | 0.24 |
| EPS Actual | 0.14 | 0.30 | 0.24 | 0.20 |
| Revenue Estimate | 105.08M | 107.59M | 101.00M | 98.88M |
| Revenue Actual | 103.06M | 101.73M | 103.39M | 93.70M |
To track all earnings releases for Corcept Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
